MCRB icon

Seres Therapeutics

137 hedge funds and large institutions have $538M invested in Seres Therapeutics in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.8M
Puts
$4.23M
Net Calls
Net Calls Change

Top Buyers

1 +$23M
2 +$9.8M
3 +$6.47M
4
BlackRock
BlackRock
New York
+$5.9M
5
ACA
Avoro Capital Advisors
New York
+$5.77M

Top Sellers

1 -$25M
2 -$18.6M
3 -$4.36M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.38M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.34M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$534K
52
$499K
53
$491K
54
$474K
55
$467K
56
$456K
57
$455K
58
$432K
59
$418K
60
$415K
61
$410K
62
$382K
63
$378K
64
$351K
65
$315K
66
$292K
67
$260K
68
$246K
69
$240K
70
$236K
71
$232K
72
$225K
73
$224K
74
$217K
75
$215K